Normal view
-
cs.AI, q-bio.NC updates on arXiv.org
-
AI Safeguards, Generative AI and the Pandora Box: AI Safety Measures to Protect Businesses and Personal Reputation
arXiv:2601.06197v1 Announce Type: new Abstract: Generative AI has unleashed the power of content generation and it has also unwittingly opened the pandora box of realistic deepfake causing a number of social hazards and harm to businesses and personal reputation. The investigation & ramification of Generative AI technology across industries, the resolution & hybridization detection techniques using neural networks allows flagging of the content. Good detection techniques & flagging
-
cs.AI, q-bio.NC updates on arXiv.org
-
ConSensus: Multi-Agent Collaboration for Multimodal Sensing
arXiv:2601.06453v1 Announce Type: new Abstract: Large language models (LLMs) are increasingly grounded in sensor data to perceive and reason about human physiology and the physical world. However, accurately interpreting heterogeneous multimodal sensor data remains a fundamental challenge. We show that a single monolithic LLM often fails to reason coherently across modalities, leading to incomplete interpretations and prior-knowledge bias. We introduce ConSensus, a training-free multi-agent col
ConSensus: Multi-Agent Collaboration for Multimodal Sensing
-
cs.AI, q-bio.NC updates on arXiv.org
-
Why Slop Matters
arXiv:2601.06060v1 Announce Type: cross Abstract: AI-generated "slop" is often seen as digital pollution. We argue that this dismissal of the topic risks missing important aspects of AI Slop that deserve rigorous study. AI Slop serves a social function: it offers a supply-side solution to a variety of problems in cultural and economic demand - that, collectively, people want more content than humans can supply. We also argue that AI Slop is not mere digital detritus but has its own aesthetic va
Why Slop Matters
-
cs.AI, q-bio.NC updates on arXiv.org
-
The Patient/Industry Trade-off in Medical Artificial Intelligence
arXiv:2601.06144v1 Announce Type: cross Abstract: Artificial intelligence (AI) in healthcare has led to many promising developments; however, increasingly, AI research is funded by the private sector leading to potential trade-offs between benefits to patients and benefits to industry. Health AI practitioners should prioritize successful adaptation into clinical practice in order to provide meaningful benefits to patients, but translation usually requires collaboration with industry. We discuss
The Patient/Industry Trade-off in Medical Artificial Intelligence
-
cs.AI, q-bio.NC updates on arXiv.org
-
$\texttt{AMEND++}$: Benchmarking Eligibility Criteria Amendments in Clinical Trials
arXiv:2601.06300v1 Announce Type: cross Abstract: Clinical trial amendments frequently introduce delays, increased costs, and administrative burden, with eligibility criteria being the most commonly amended component. We introduce \textit{eligibility criteria amendment prediction}, a novel NLP task that aims to forecast whether the eligibility criteria of an initial trial protocol will undergo future amendments. To support this task, we release $\texttt{AMEND++}$, a benchmark suite comprising t
$\texttt{AMEND++}$: Benchmarking Eligibility Criteria Amendments in Clinical Trials
-
cs.AI, q-bio.NC updates on arXiv.org
-
A Large-Scale Study on the Development and Issues of Multi-Agent AI Systems
arXiv:2601.07136v1 Announce Type: cross Abstract: The rapid emergence of multi-agent AI systems (MAS), including LangChain, CrewAI, and AutoGen, has shaped how large language model (LLM) applications are developed and orchestrated. However, little is known about how these systems evolve and are maintained in practice. This paper presents the first large-scale empirical study of open-source MAS, analyzing over 42K unique commits and over 4.7K resolved issues across eight leading systems. Our ana
A Large-Scale Study on the Development and Issues of Multi-Agent AI Systems
-
cs.AI, q-bio.NC updates on arXiv.org
-
Learning from Reasoning Failures via Synthetic Data Generation
arXiv:2504.14523v2 Announce Type: replace Abstract: Training models on synthetic data has emerged as an increasingly important strategy for improving the performance of generative AI. This approach is particularly helpful for large multimodal models (LMMs) due to the relative scarcity of high-quality paired image-text data compared to language-only data. While a variety of methods have been proposed for generating large multimodal datasets, they do not tailor the synthetic data to address speci
Learning from Reasoning Failures via Synthetic Data Generation
-
cs.AI, q-bio.NC updates on arXiv.org
-
FairMedQA: Benchmarking Bias in Large Language Models for Medical Question Answering
arXiv:2505.19562v2 Announce Type: replace Abstract: Large language models (LLMs) are approaching expert-level performance in medical question answering (QA), demonstrating strong potential to improve public healthcare. However, underlying biases related to sensitive attributes such as sex and race pose life-critical risks. The extent to which such sensitive attributes affect diagnosis remains an open question and requires comprehensive empirical investigation. Additionally, even the latest Coun
FairMedQA: Benchmarking Bias in Large Language Models for Medical Question Answering
-
cs.AI, q-bio.NC updates on arXiv.org
-
From Wearables to Warnings: Predicting Pain Spikes in Patients with Opioid Use Disorder
arXiv:2511.19577v2 Announce Type: replace Abstract: Chronic pain (CP) and opioid use disorder (OUD) are common and interrelated chronic medical conditions. Currently, there is a paucity of evidence-based integrated treatments for CP and OUD among individuals receiving medication for opioid use disorder (MOUD). Wearable devices have the potential to monitor complex patient information and inform treatment development for persons with OUD and CP, including pain variability (e.g., exacerbations of
From Wearables to Warnings: Predicting Pain Spikes in Patients with Opioid Use Disorder
-
cs.AI, q-bio.NC updates on arXiv.org
-
Reqo: A Comprehensive Learning-Based Cost Model for Robust and Explainable Query Optimization
arXiv:2501.17414v2 Announce Type: replace-cross Abstract: Although machine learning (ML) shows potential in improving query optimization by generating and selecting more efficient plans, ensuring the robustness of learning-based cost models (LCMs) remains challenging. These LCMs currently lack explainability, which undermines user trust and limits the ability to derive insights from their cost predictions to improve plan quality. Accurately converting tree-structured query plans into representa
Reqo: A Comprehensive Learning-Based Cost Model for Robust and Explainable Query Optimization
-
TechCrunch
-
Anthropic announces Claude for Healthcare following OpenAI’s ChatGPT Health reveal
Anthropic's Claude for Healthcare is unveiled about a week after OpenAI announced its ChatGPT Health product.
Anthropic announces Claude for Healthcare following OpenAI’s ChatGPT Health reveal
-
Journal of Medical Internet Research
-
Key Information Influencing Patient Decision-Making About AI in Health Care: Survey Experiment Study
Background: Artificial Intelligence (AI)-enabled devices are increasingly used in healthcare. However, there has been limited research on patients’ informational preferences, including which elements of AI device labeling enhance patient understanding, trust, and acceptance. Clear and effective patient-facing communication is essential to address patient concerns and support informed decision-making regarding AI-enabled care. Objective: Using simulated AI device labels in a cardiovascular contex
Key Information Influencing Patient Decision-Making About AI in Health Care: Survey Experiment Study
-
Nature Medicine
-
Interpretable inflammation landscape of circulating immune cells
Nature Medicine, Published online: 12 January 2026; doi:10.1038/s41591-025-04126-3Including data from 1,047 patients across 19 inflammatory diseases, a new atlas presents a comprehensive model of inflammation in circulating immune cells.
Interpretable inflammation landscape of circulating immune cells
Nature Medicine, Published online: 12 January 2026; doi:10.1038/s41591-025-04126-3
Including data from 1,047 patients across 19 inflammatory diseases, a new atlas presents a comprehensive model of inflammation in circulating immune cells.-
cs.AI, q-bio.NC updates on arXiv.org
-
The Evaluation Gap in Medicine, AI and LLMs: Navigating Elusive Ground Truth & Uncertainty via a Probabilistic Paradigm
arXiv:2601.05500v1 Announce Type: new Abstract: Benchmarking the relative capabilities of AI systems, including Large Language Models (LLMs) and Vision Models, typically ignores the impact of uncertainty in the underlying ground truth answers from experts. This ambiguity is particularly consequential in medicine where uncertainty is pervasive. In this paper, we introduce a probabilistic paradigm to theoretically explain how high certainty in ground truth answers is almost always necessary for e
The Evaluation Gap in Medicine, AI and LLMs: Navigating Elusive Ground Truth & Uncertainty via a Probabilistic Paradigm
-
cs.AI, q-bio.NC updates on arXiv.org
-
A Survey of Agentic AI and Cybersecurity: Challenges, Opportunities and Use-case Prototypes
arXiv:2601.05293v1 Announce Type: cross Abstract: Agentic AI marks an important transition from single-step generative models to systems capable of reasoning, planning, acting, and adapting over long-lasting tasks. By integrating memory, tool use, and iterative decision cycles, these systems enable continuous, autonomous workflows in real-world environments. This survey examines the implications of agentic AI for cybersecurity. On the defensive side, agentic capabilities enable continuous monit
A Survey of Agentic AI and Cybersecurity: Challenges, Opportunities and Use-case Prototypes
-
MRD
-
Personalizing Treatment for Pancreatic Ductal Adenocarcinoma: The Emerging Role of Minimal Residual Disease in Perioperative Decision-Making
Cancers (Basel). 2025 Dec 27;18(1):94. doi: 10.3390/cancers18010094.ABSTRACTPancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with poor long-term survival despite advances in surgical techniques, systemic therapies, and perioperative management. High rates of systemic recurrence following curative-intent resection suggest that many patients harbor minimal residual disease (MRD), microscopic tumor burden that persists postoperatively and remains undetectable by conventiona
Personalizing Treatment for Pancreatic Ductal Adenocarcinoma: The Emerging Role of Minimal Residual Disease in Perioperative Decision-Making
Cancers (Basel). 2025 Dec 27;18(1):94. doi: 10.3390/cancers18010094.
ABSTRACT
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with poor long-term survival despite advances in surgical techniques, systemic therapies, and perioperative management. High rates of systemic recurrence following curative-intent resection suggest that many patients harbor minimal residual disease (MRD), microscopic tumor burden that persists postoperatively and remains undetectable by conventional diagnostic tools. Recent advances in liquid biopsy technologies, particularly circulating tumor DNA (ctDNA) analysis, alongside detailed characterization of the PDAC mutational landscape, offer a promising non-invasive approach for MRD detection. Emerging evidence indicates that MRD status can serve as a sensitive prognostic biomarker, identify patients at high risk of relapse, and guide personalized perioperative therapy, including optimization of adjuvant treatment. This review summarizes current knowledge on the biology and detection of MRD in PDAC, its implications for perioperative risk stratification and treatment decision-making, and discusses future directions for integrating MRD assessment into clinical practice to enable more precise, individualized patient management.
PMID:41514607 | PMC:PMC12784771 | DOI:10.3390/cancers18010094
-
Nature Medicine
-
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial
Nature Medicine, Published online: 09 January 2026; doi:10.1038/s41591-025-04170-zAnalysis of a placebo-controlled trial of a BCMA-targeting CAR-T cell therapy in patients with myasthenia gravis shows that CAR-T cell infusion selectively remodels the systemic immune environment, with elimination of BCMA-high plasma cells and activated plasmacytoid dendritic cells and changes in the autoreactive B cell repertoire.
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial
Nature Medicine, Published online: 09 January 2026; doi:10.1038/s41591-025-04170-z
Analysis of a placebo-controlled trial of a BCMA-targeting CAR-T cell therapy in patients with myasthenia gravis shows that CAR-T cell infusion selectively remodels the systemic immune environment, with elimination of BCMA-high plasma cells and activated plasmacytoid dendritic cells and changes in the autoreactive B cell repertoire.-
Nature Medicine
-
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial
Nature Medicine, Published online: 09 January 2026; doi:10.1038/s41591-025-04171-yIn a randomized, double-blind, placebo-controlled trial comparing autologous mRNA-engineered BCMA-targeting CAR T cell therapy versus placebo in patients with generalized myasthenia gravis, a significantly higher percentage of patients exhibited a reduction in disease activity in the treatment arm than in the placebo arm.
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial
Nature Medicine, Published online: 09 January 2026; doi:10.1038/s41591-025-04171-y
In a randomized, double-blind, placebo-controlled trial comparing autologous mRNA-engineered BCMA-targeting CAR T cell therapy versus placebo in patients with generalized myasthenia gravis, a significantly higher percentage of patients exhibited a reduction in disease activity in the treatment arm than in the placebo arm.-
cs.AI, q-bio.NC updates on arXiv.org
-
Sci-Reasoning: A Dataset Decoding AI Innovation Patterns
arXiv:2601.04577v1 Announce Type: new Abstract: While AI innovation accelerates rapidly, the intellectual process behind breakthroughs -- how researchers identify gaps, synthesize prior work, and generate insights -- remains poorly understood. The lack of structured data on scientific reasoning hinders systematic analysis and development of AI research agents. We introduce Sci-Reasoning, the first dataset capturing the intellectual synthesis behind high-quality AI research. Using community-vali
Sci-Reasoning: A Dataset Decoding AI Innovation Patterns
-
cs.AI, q-bio.NC updates on arXiv.org
-
Beyond Monolithic Architectures: A Multi-Agent Search and Knowledge Optimization Framework for Agentic Search
arXiv:2601.04703v1 Announce Type: new Abstract: Agentic search has emerged as a promising paradigm for complex information seeking by enabling Large Language Models (LLMs) to interleave reasoning with tool use. However, prevailing systems rely on monolithic agents that suffer from structural bottlenecks, including unconstrained reasoning outputs that inflate trajectories, sparse outcome-level rewards that complicate credit assignment, and stochastic search noise that destabilizes learning. To a